Baxter ROE 2006-2018 | BAX

Current and historical return on equity (ROE) values for Baxter (BAX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Baxter ROE for the three months ending December 31, 2018 was 19.10%.
Baxter ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $1.62B $7.82B 18.62%
2018-09-30 $1.21B $9.11B 13.32%
2018-06-30 $0.91B $8.87B 9.98%
2018-03-31 $0.83B $9.09B 9.06%
2017-12-31 $0.72B $9.12B 7.88%
2017-09-30 $1.03B $9.46B 11.59%
2017-06-30 $0.91B $9.17B 10.46%
2017-03-31 $1.86B $8.68B 21.76%
2016-12-31 $4.97B $8.28B 57.61%
2016-09-30 $4.93B $8.66B 56.21%
2016-06-30 $4.80B $8.51B 56.05%
2016-03-31 $3.92B $9.02B 46.43%
2015-12-31 $0.97B $8.87B 12.09%
2015-09-30 $1.72B $7.85B 21.92%
2015-06-30 $2.18B $8.02B 27.38%
2015-03-31 $2.37B $7.29B 29.13%
2014-12-31 $2.50B $8.16B 29.41%
2014-09-30 $1.87B $8.43B 21.81%
2014-06-30 $1.95B $8.69B 23.16%
2014-03-31 $2.02B $8.69B 25.01%
2013-12-31 $2.01B $8.49B 26.35%
2013-09-30 $2.18B $7.75B 30.03%
2013-06-30 $2.22B $7.32B 31.16%
2013-03-31 $2.29B $7.00B 32.97%
2012-12-31 $2.33B $6.98B 33.54%
2012-09-30 $2.30B $7.19B 33.27%
2012-06-30 $2.29B $6.61B 33.17%
2012-03-31 $2.24B $6.96B 31.77%
2011-12-31 $2.22B $6.83B 31.51%
2011-09-30 $2.18B $7.19B 30.98%
2011-06-30 $2.13B $7.24B 30.72%
2011-03-31 $2.05B $6.97B 30.80%
2010-12-31 $1.42B $6.80B 21.55%
2010-09-30 $1.57B $6.76B 23.27%
2010-06-30 $1.57B $6.13B 22.87%
2010-03-31 $1.63B $6.66B 23.09%
2009-12-31 $2.21B $7.42B 31.88%
2009-09-30 $2.20B $7.31B 33.20%
2009-06-30 $2.14B $6.77B 32.63%
2009-03-31 $2.10B $6.16B 31.44%
2008-12-31 $2.01B $6.29B 29.22%
2008-09-30 $1.92B $7.06B 27.29%
2008-06-30 $1.85B $7.22B 26.93%
2008-03-31 $1.73B $7.00B 25.78%
2007-12-31 $1.71B $6.92B 25.77%
2007-09-30 $1.66B $6.29B 25.70%
2007-06-30 $1.64B $6.69B 25.33%
2007-03-31 $1.52B $6.60B 24.21%
2006-12-31 $1.40B $6.27B 23.07%
2006-09-30 $1.26B $6.34B 22.60%
2006-06-30 $1.00B $5.87B 19.70%
2006-03-31 $1.01B $5.75B 21.73%
2005-12-31 $0.96B $4.30B 22.63%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $39.019B $11.127B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $133.667B 26.06
Medtronic (MDT) Ireland $114.132B 16.69
Stryker (SYK) United States $69.756B 24.90
Boston Scientific (BSX) United States $49.905B 24.25
Zimmer Biomet Holdings (ZBH) United States $25.114B 16.07
Smith & Nephew SNATS (SNN) United Kingdom $16.786B 0.00
Canopy Growth (CGC) Canada $16.315B 0.00
ResMed (RMD) United States $14.544B 27.58
Aurora Cannabis (ACB) Canada $9.179B 64.71
Bio-Rad Laboratories (BIO) United States $8.795B 50.45
Perrigo (PRGO) Ireland $6.734B 10.92
Hill-Rom Holdings (HRC) United States $6.397B 19.79
GW Pharmaceuticals (GWPH) United Kingdom $4.994B 0.00
Insulet (PODD) United States $4.964B 1664.20
ICU Medical (ICUI) United States $4.636B 28.71
Haemonetics (HAE) United States $4.354B 38.62
Hutchison China MediTech (HCM) China $3.962B 0.00
Agios Pharmaceuticals (AGIO) United States $3.443B 0.00
Neogen (NEOG) United States $3.004B 48.85
NuVasive (NUVA) United States $2.967B 25.77
Quidel (QDEL) United States $2.487B 22.25
National Vision Holdings (EYE) United States $2.276B 44.77
Aphria (APHA) $1.957B 0.00
HEXO (HEXO) $1.474B 0.00
Phibro Animal Health (PAHC) United States $1.338B 19.24
VAREX IMAGING (VREX) United States $1.234B 24.16
Cardiovascular Systems (CSII) United States $1.212B 870.25
AtriCure (ATRC) United States $1.076B 0.00
Lantheus Holdings (LNTH) United States $0.957B 25.86
Omeros (OMER) United States $0.929B 0.00
PetIQ (PETQ) United States $0.865B 24.76
Cerus (CERS) United States $0.831B 0.00
MacroGenics (MGNX) United States $0.820B 0.00
NanoString Technologies (NSTG) United States $0.781B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.725B 24.66
TG Therapeutics (TGTX) United States $0.717B 0.00
Evolus (EOLS) United States $0.708B 0.00
OraSure Technologies (OSUR) United States $0.589B 25.68
Surmodics (SRDX) United States $0.584B 84.94
LeMaitre Vascular (LMAT) United States $0.555B 26.37
Meridian Bioscience (VIVO) United States $0.538B 16.02
Quanterix (QTRX) United States $0.515B 0.00
Insys Therapeutics (INSY) United States $0.332B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.329B 0.00
Utah Medical Products (UTMD) United States $0.326B 21.19
BioLife Solutions (BLFS) United States $0.302B 124.61
Vapotherm (VAPO) United States $0.287B 0.00
Rockwell Medical (RMTI) United States $0.270B 0.00
Cytosorbents (CTSO) United States $0.228B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.172B 18.38
Bovie Medical (APYX) United States $0.140B 0.00
Chimerix (CMRX) United States $0.138B 0.00
Fonar (FONR) United States $0.128B 6.85
Chembio Diagnostics (CEMI) United States $0.122B 0.00
Surface Oncology (SURF) United States $0.114B 0.00
United-Guardian (UG) United States $0.089B 20.32
Female Health (VERU) United States $0.088B 0.00
InfuSystems Holdings (INFU) United States $0.085B 0.00
Neurotrope (NTRP) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 19.86
GUARDION HEALTH (GHSI) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.024B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 13.00